{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:13:22Z","timestamp":1790399602050,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014538","name":"Lembaga Pengelola Dana Pendidikan","doi-asserted-by":"publisher","award":["201908223215121"],"award-info":[{"award-number":["201908223215121"]}],"id":[{"id":"10.13039\/501100014538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Effective hypertension management requires medication adherence to prevent complications. However, adverse drug reactions (ADRs) can undermine adherence and negatively affect patients\u2019 quality of life. Limited research has explored the association between ADRs, medication adherence, and health-related quality of life (HRQoL) in individuals with hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To investigate the association between ADRs, medication adherence, and HRQoL among patients with hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A cross-sectional study using telephone interviews and medical record reviews was conducted in 11 primary care facilities in Indonesia. The causality of reported ADRs was assessed using the Naranjo algorithm, validated by a panel of experts in pharmacy practice and medication safety. The severity of ADRs was classified using the Hartwig scale. Adherence to antihypertensive drugs was estimated using the Medication Adherence Report Scale-5 (MARS-5). The EuroQoL EQ-5D-5L was used to measure HRQoL. The association between ADRs and medication adherence was assessed using multivariate logistic regression, while the association with HRQoL was evaluated through the Tobit regression model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 507 patients were included in this study. We found that 20.32% (n\u2009=\u2009103) of the patients experienced ADRs, with the most commonly reported ADRs being polyuria and urgency, gastrointestinal symptoms, leg swelling, dizziness\/hypotension, palpitations, and dry cough. The majority experienced mild ADRs (n\u2009=\u200975, 72.82%), while 27.18% (n\u2009=\u200928) had reactions of moderate severity. Experiencing ADRs was associated with reduced medication adherence (adjusted odds ratio (OR) 7.15, 95% CI 4.07\u201312.55) and decreased HRQoL (coefficient: \u2212 0.037).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients experiencing ADRs were seven times more likely to be non-adherent to their medication regimen and reported a reduced quality of life compared to those without ADRs, placing them at a higher risk of suboptimal treatment outcomes. This finding highlights the need for additional monitoring and education for patients affected by ADRs, particularly through more frequent clinical and laboratory assessments, timely management of ADRs, and personalized education on the importance of adherence to prevent hypertension-related complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-024-01832-9","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:37:20Z","timestamp":1732768640000},"page":"354-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0066-9746","authenticated-orcid":false,"given":"Widya N.","family":"Insani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizky","family":"Abdulah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofa D.","family":"Alfian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurul A.","family":"Ramadhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizky","family":"Andhika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neily","family":"Zakiyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Adesuyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunisa","family":"Pamela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-2272","authenticated-orcid":false,"given":"Cate","family":"Whittlesea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"issue":"18","key":"1832_CR1","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","volume":"328","author":"RM Carey","year":"2022","unstructured":"Carey RM, Moran AE, Whelton PK. Treatment of hypertension: a review. JAMA. 2022;328(18):1849\u201361.","journal-title":"JAMA"},{"issue":"4","key":"1832_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1832_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12872-023-03357-x","volume":"23","author":"F Farhadi","year":"2023","unstructured":"Farhadi F, Aliyari R, Ebrahimi H, et al. Prevalence of uncontrolled hypertension and its associated factors in 50\u201374 years old Iranian adults: a population-based study. BMC Cardiovasc Disord. 2023;23(1):318.","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"1832_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212572","volume":"14","author":"S Meelab","year":"2019","unstructured":"Meelab S, Bunupuradah I, Suttiruang J, et al. Prevalence and associated factors of uncontrolled blood pressure among hypertensive patients in the rural communities in the central areas in Thailand: a cross-sectional study. PLoS ONE. 2019;14(2): e0212572.","journal-title":"PLoS ONE"},{"issue":"9","key":"1832_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011793","volume":"8","author":"P Shang","year":"2019","unstructured":"Shang P, Liu GG, Zheng X, et al. Association between medication adherence and 1-year major cardiovascular adverse events after acute myocardial infarction in China. J Am Heart Assoc. 2019;8(9): e011793.","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"1832_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026582","volume":"11","author":"EKP Lee","year":"2022","unstructured":"Lee EKP, Poon P, Yip BHK, et al. Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta-analysis involving 27 million patients. J Am Heart Assoc. 2022;11(17): e026582.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1832_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/HJH.0b013e328342ca97","volume":"29","author":"G Corrao","year":"2011","unstructured":"Corrao G, Parodi A, Nicotra F, Zambon A, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29(3):610\u20138. https:\/\/doi.org\/10.1097\/HJH.0b013e328342ca97.","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"1832_CR8","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1517\/14740338.2014.947260","volume":"13","author":"C Leporini","year":"2014","unstructured":"Leporini C, De Sarro G, Russo E. Adherence to therapy and adverse drug reactions: is there a link? Expert Opin Drug Saf. 2014;13(Suppl 1):S41-55.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"1832_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s11096-017-0583-7","volume":"40","author":"TM Alhawassi","year":"2018","unstructured":"Alhawassi TM, Krass I, Pont LG. Antihypertensive-related adverse drug reactions among older hospitalized adults. Int J Clin Pharm. 2018;40(2):428\u201335.","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"1832_CR10","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1111\/bcp.13312","volume":"83","author":"DF Berhe","year":"2017","unstructured":"Berhe DF, Taxis K, Haaijer-Ruskamp FM, et al. Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication\u2014a study in ambulatory patients. Br J Clin Pharmacol. 2017;83(9):2107\u201317.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"1832_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/jhh.2009.116","volume":"24","author":"TF Butt","year":"2010","unstructured":"Butt TF, Branch RL, Beesley L, et al. Managing hypertension in the very elderly: effect of adverse drug reactions on achieving targets. J Hum Hypertens. 2010;24(8):514\u20138.","journal-title":"J Hum Hypertens"},{"issue":"3","key":"1832_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4103\/aam.aam_6_17","volume":"16","author":"AO Olowofela","year":"2017","unstructured":"Olowofela AO, Isah AO. A profile of adverse effects of antihypertensive medicines in a tertiary care clinic in Nigeria. Ann Afr Med. 2017;16(3):114\u20139.","journal-title":"Ann Afr Med"},{"key":"1832_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n189","volume":"372","author":"A Albasri","year":"2021","unstructured":"Albasri A, Hattle M, Koshiaris C, et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. 2021;372: n189.","journal-title":"BMJ"},{"issue":"613","key":"1832_CR14","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.3399\/bjgp13X670660","volume":"63","author":"C Tsang","year":"2013","unstructured":"Tsang C, Bottle A, Majeed A, et al. Adverse events recorded in English primary care: observational study using the general practice research database. Br J Gen Pract. 2013;63(613):e534-542.","journal-title":"Br J Gen Pract"},{"issue":"6","key":"1832_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00228-017-2225-3","volume":"73","author":"TJ Oscanoa","year":"2017","unstructured":"Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly: a meta-analysis. Eur J Clin Pharmacol. 2017;73(6):759\u201370.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1832_CR16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s11096-024-01730-0","volume":"46","author":"Q Hu","year":"2024","unstructured":"Hu Q, Zhao M, Teng F, et al. A model for identifying potentially inappropriate medication used in older people with dementia: a machine learning study. Int J Clin Pharm. 2024;46(4):937\u201346.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"1832_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/14740338.2023.2244421","volume":"23","author":"J Kuteesa","year":"2024","unstructured":"Kuteesa J, Nasasira M, Kiguba R. Epidemiology of adverse drug reactions to antihypertensive, antithrombotic and antidiabetic medications among adult inpatients at a National Referral Hospital, Uganda. Expert Opin Drug Saf. 2024;23(1):129\u201336.","journal-title":"Uganda Expert Opin Drug Saf"},{"issue":"10","key":"1832_CR18","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1007\/s11606-020-05809-y","volume":"35","author":"SD Alfian","year":"2020","unstructured":"Alfian SD, Annisa N, Fajriansyah F, et al. Modifiable factors associated with non-adherence to antihypertensive or antihyperlipidemic drugs are dissimilar: a multicenter study among patients with diabetes in Indonesia. J Gen Intern Med. 2020;35(10):2897\u2013906.","journal-title":"J Gen Intern Med"},{"key":"1832_CR19","unstructured":"World Health Organization. (1969). International drug monitoring: technical report series No. 425 [Page 6]. Geneva: World Health Organization"},{"issue":"8","key":"1832_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.7326\/0003-4819-117-8-634","volume":"117","author":"EA Chrischilles","year":"1992","unstructured":"Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse drug reactions and related resource use: a study of community-dwelling persons 65 years of age and older. Ann Intern Med. 1992;117(8):634\u201340.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1832_CR21","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/1475-6773.13173","volume":"54","author":"JL Hargraves","year":"2019","unstructured":"Hargraves JL, Cosenza C, Elliott MN, et al. The effect of different sampling and recall periods in the CAHPS clinician & group survey. Health Serv Res. 2019;54(5):1036\u201344.","journal-title":"Health Serv Res"},{"issue":"2","key":"1832_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1832_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11096-023-01669-8","volume":"46","author":"S Kampichit","year":"2024","unstructured":"Kampichit S, Srisuriyachanchai W, Pratipanawatr T, et al. Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study. Int J Clin Pharm. 2024;46(2):401\u201310.","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"1832_CR24","first-page":"2229","volume":"49","author":"SC Hartwig","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229\u201332.","journal-title":"Am J Hosp Pharm"},{"issue":"1","key":"1832_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/08870440290001502","volume":"17","author":"R Horne","year":"2002","unstructured":"Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17\u201332.","journal-title":"Psychol Health"},{"key":"1832_CR26","first-page":"176","volume":"2","author":"R Alfian","year":"2017","unstructured":"Alfian R, Putra AMP. The validity and reliability test of the Medication Adherence Report Scale (MARS) questionnaire for diabetes mellitus patients in Indonesia. J Ilm Ibnu Sina. 2017;2:176\u201383.","journal-title":"J Ilm Ibnu Sina"},{"issue":"10","key":"1832_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017293","volume":"7","author":"L Wei","year":"2017","unstructured":"Wei L, Champman S, Li X, et al. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China. BMJ Open. 2017;7(10): e017293.","journal-title":"BMJ Open"},{"issue":"8","key":"1832_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002749","volume":"3","author":"C Easthall","year":"2013","unstructured":"Easthall C, Song F, Bhattacharya D. A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence. BMJ Open. 2013;3(8): e002749.","journal-title":"BMJ Open"},{"issue":"10","key":"1832_CR29","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"1","key":"1832_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hec.3564","volume":"27","author":"NJ Devlin","year":"2018","unstructured":"Devlin NJ, Shah KK, Feng Y, et al. Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 2018;27(1):7\u201322.","journal-title":"Health Econ"},{"issue":"6","key":"1832_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40273-018-0615-8","volume":"36","author":"K Ludwig","year":"2018","unstructured":"Ludwig K, Graf JM, Greiner W. German value set for the EQ-5D-5L. Pharmacoeconomics. 2018;36(6):663\u201374.","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"1832_CR32","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s40273-017-0538-9","volume":"35","author":"FD Purba","year":"2017","unstructured":"Purba FD, Hunfeld JAM, Iskandarsyah A, et al. The Indonesian EQ-5D-5L value set. Pharmacoeconomics. 2017;35(11):1153\u201365.","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"1832_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000368191","volume":"61","author":"PS Nishtala","year":"2015","unstructured":"Nishtala PS, Salahudeen MS. Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005\u20132013. Gerontology. 2015;61(3):195\u2013202.","journal-title":"Gerontology"},{"issue":"9","key":"1832_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032544","volume":"9","author":"ELY Wong","year":"2019","unstructured":"Wong ELY, Xu RH, Cheung AWL. Health-related quality of life among patients with hypertension: population-based survey using EQ-5D-5L in Hong Kong SAR, China. BMJ Open. 2019;9(9): e032544.","journal-title":"BMJ Open"},{"key":"1832_CR35","first-page":"2023","volume-title":"Stata Statistical Software: Release 18","author":"StataCorp.","year":"2023","unstructured":"StataCorp. Stata Statistical Software: Release 18. College Station, TX: StataCorp LLC; 2023. p. 2023."},{"issue":"2","key":"1832_CR36","first-page":"117","volume":"92","author":"LA Anghel","year":"2019","unstructured":"Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019;92(2):117\u201322.","journal-title":"Med Pharm Rep"},{"issue":"7","key":"1832_CR37","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S0895-4356(02)00400-6","volume":"55","author":"JP Gregoire","year":"2002","unstructured":"Gregoire JP, Moisan J, Guibert R, et al. Determinants of discontinuation of new courses of antihypertensive medications. J Clin Epidemiol. 2002;55(7):728\u201335.","journal-title":"J Clin Epidemiol"},{"issue":"Suppl 1","key":"1832_CR38","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.4103\/0976-500X.120957","volume":"4","author":"J Sultana","year":"2013","unstructured":"Sultana J, Cutroneo P, Trifiro G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(Suppl 1):S73-77.","journal-title":"J Pharmacol Pharmacother"},{"issue":"5","key":"1832_CR39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/archinte.163.5.592","volume":"163","author":"SJ Davies","year":"2003","unstructured":"Davies SJ, Jackson PR, Ramsay LE, et al. Drug intolerance due to nonspecific adverse effects related to psychiatric morbidity in hypertensive patients. Arch Intern Med. 2003;163(5):592\u2013600.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1832_CR40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/ijpp\/riac052","volume":"30","author":"SM Altawalbeh","year":"2022","unstructured":"Altawalbeh SM, Almomani BA, Alefan Q, et al. The influence of adverse drug effects on health-related quality of life in chronic obstructive pulmonary disease patients. Int J Pharm Pract. 2022;30(5):457\u201365.","journal-title":"Int J Pharm Pract"},{"issue":"3","key":"1832_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1464-5491.2011.03416.x","volume":"29","author":"S Barendse","year":"2012","unstructured":"Barendse S, Singh H, Frier BM, et al. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review. Diabet Med. 2012;29(3):293\u2013302.","journal-title":"Diabet Med"},{"issue":"3","key":"1832_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4103\/0253-7176.207332","volume":"39","author":"S Chawla","year":"2017","unstructured":"Chawla S, Kumar S. Adverse drug reactions and their impact on quality of life in patients on antipsychotic therapy at a tertiary care center in Delhi. Indian J Psychol Med. 2017;39(3):293\u20138.","journal-title":"Indian J Psychol Med"},{"key":"1832_CR43","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2147\/PPA.S92125","volume":"9","author":"M Kekale","year":"2015","unstructured":"Kekale M, Peltoniemi M, Airaksinen M. Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment. Patient Prefer Adherence. 2015;9:1733\u201340.","journal-title":"Patient Prefer Adherence"},{"issue":"8","key":"1832_CR44","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s40264-016-0422-0","volume":"39","author":"L Rolfes","year":"2016","unstructured":"Rolfes L, van Hunsel F, Taxis K. The impact of experiencing adverse drug reactions on the patient\u2019s quality of life: a retrospective cross-sectional study in the Netherlands. Drug Saf. 2016;39(8):769\u201376.","journal-title":"Drug Saf"},{"issue":"7","key":"1832_CR45","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1359105321995916","volume":"27","author":"S Akyirem","year":"2022","unstructured":"Akyirem S, Forbes A, Wad JL, et al. Psychosocial interventions for adults with newly diagnosed chronic disease: a systematic review. J Health Psychol. 2022;27(7):1753\u201382.","journal-title":"J Health Psychol"},{"key":"1832_CR46","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.2147\/PPA.S368784","volume":"16","author":"SM Hamrahian","year":"2022","unstructured":"Hamrahian SM, Maarouf OH, Fulop T. A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider. Patient Prefer Adherence. 2022;16:2749\u201357.","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"1832_CR47","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","volume":"26","author":"E Vermeire","year":"2001","unstructured":"Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research: a comprehensive review. J Clin Pharm Ther. 2001;26(5):331\u201342.","journal-title":"J Clin Pharm Ther"},{"key":"1832_CR48","doi-asserted-by":"publisher","DOI":"10.2196\/39490","volume":"7","author":"D Dorr","year":"2023","unstructured":"Dorr D, D\u2019Autremont C, Richardson JE, et al. Patient-facing clinical decision support for high blood pressure control: patient survey. JMIR Cardio. 2023;7: e39490.","journal-title":"JMIR Cardio"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01832-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01832-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01832-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:46:26Z","timestamp":1742316386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01832-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01832-9","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}